E Alton Sartor1, Karen Albright2, Amelia K Boehme3, Miriam M Morales4, Amir Shaban5, James C Grotta6, Sean I Savitz, Sheryl Martin-Schild. 1. Stroke Program, Department of Neurology, Tulane University Medical School, USA. 2. Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, USA. 3. Services and Outcomes Research Center for Outcome and Effectiveness Research and Education (COERE), School of Medicine, University of Alabama at Birmingham, USA. 4. Center of Excellence in Comparative Effectiveness Research for Eliminating Disparities (CERED) Minority Health & Health Disparities Research Center (MHRC), School of Medicine, University of Alabama at Birmingham, 35294. 5. Memorial Herman Hospital, USA. 6. Stroke Program, Department of Neurology, University of Texas in Houston, USA.
Abstract
BACKGROUND: Neuroprotective agents have the potential to reduce ischemia to penumbra of the cortex, but are time-sensitive. To quickly determine whether a cortical stroke is present without imaging, we created a scoring system based on the NIH stroke scale (NIHSS) that can accurately predict cortical damage in an acute ischemic stroke (AIS). METHODS: Patients treated with tPA for AIS were retrospectively assessed through prospectively acquired databases at two stroke centers. Stroke was classified as cortical vs. non-cortical stroke. The total NIHSS score, cortical components (gaze, visual fields, language, and neglect) and cortical score (sum of cortical components) were analyzed for site 1 and then validated for site 2 for sensitivity and positive predictive value (PPV) for a cortical stroke. RESULTS: An acute infarct was detected in 194/239 (81%) patients at site 1 and 122/174 (70%) at site 2 on diffusion-weighted MRI. Cortical involvement was found in 71% (site 1) and 75% (site 2). The median cortical score was 25% of the total NIHSS score at both sites. NIHSS ≥ 4 had the highest sensitivity; PPV was 90% for any cortical sign with ≥ 2 points. The best combination of sensitivity and PPV was cortical score/NIHSS score ≥10%. DISCUSSION: If a trial targeting cortical stroke required that the cortical score represent at least 10% of the total NIHSS score with no imaging, less than 10% of patients with cortical stroke would be missed and less than 18% of patients would be misclassified as having a cortical stroke.
BACKGROUND: Neuroprotective agents have the potential to reduce ischemia to penumbra of the cortex, but are time-sensitive. To quickly determine whether a cortical stroke is present without imaging, we created a scoring system based on the NIH stroke scale (NIHSS) that can accurately predict cortical damage in an acute ischemic stroke (AIS). METHODS:Patients treated with tPA for AIS were retrospectively assessed through prospectively acquired databases at two stroke centers. Stroke was classified as cortical vs. non-cortical stroke. The total NIHSS score, cortical components (gaze, visual fields, language, and neglect) and cortical score (sum of cortical components) were analyzed for site 1 and then validated for site 2 for sensitivity and positive predictive value (PPV) for a cortical stroke. RESULTS: An acute infarct was detected in 194/239 (81%) patients at site 1 and 122/174 (70%) at site 2 on diffusion-weighted MRI. Cortical involvement was found in 71% (site 1) and 75% (site 2). The median cortical score was 25% of the total NIHSS score at both sites. NIHSS ≥ 4 had the highest sensitivity; PPV was 90% for any cortical sign with ≥ 2 points. The best combination of sensitivity and PPV was cortical score/NIHSS score ≥10%. DISCUSSION: If a trial targeting cortical stroke required that the cortical score represent at least 10% of the total NIHSS score with no imaging, less than 10% of patients with cortical stroke would be missed and less than 18% of patients would be misclassified as having a cortical stroke.
Authors: B B Worrall; E Farace; A E Hillis; R K Hutson; R Wityk; J L Saver; K C Johnston; E C Haley Journal: Cerebrovasc Dis Date: 2001 Impact factor: 2.762
Authors: M R Frankel; L B Morgenstern; T Kwiatkowski; M Lu; B C Tilley; J P Broderick; R Libman; S R Levine; T Brott Journal: Neurology Date: 2000-10-10 Impact factor: 9.910
Authors: Ashfaq Shuaib; Kennedy R Lees; Patrick Lyden; James Grotta; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; Tim Ashwood; Warren W Wasiewski; Ugochi Emeribe Journal: N Engl J Med Date: 2007-08-09 Impact factor: 91.245